Serostim (Somatropin Injectable)

Serostim (Somatropin Injectable) – rDNA Origin For subcutaneous Injection

Serostim (Somatropin Injectable) is a medication that is used for subcutaneous injection. It contains somatropin, which is a synthetic version of human growth hormone (GH) that is produced through recombinant DNA (rDNA) technology. Subcutaneous injection refers to the administration of a medication into the fatty tissue layer just below the skin.

Usage and Dosage

Serostim is typically prescribed for the treatment of HIV patients with wasting or cachexia, which is a condition characterized by severe weight loss and muscle wasting. It is used to help increase lean body mass and improve physical endurance in these patients.

The dosage of Serostim can vary depending on the individual patient and their specific condition. It is important to follow the instructions provided by the healthcare provider and to use the medication as directed. The medication is available in vials containing either 4 mg or 5 mg of somatropin.

Administration

To administer Serostim, the lyophilized powder in the vial needs to be reconstituted with the provided diluent. The diluent is injected into the vial, and the resulting liquid is then used for subcutaneous injection. It is recommended to follow proper injection techniques and hygiene practices while administering the medication.

Side Effects and Precautions

Like any medication, Serostim can cause side effects. Common side effects may include injection site reactions (such as pain, redness, or swelling at the injection site), headache, joint pain, muscle pain, and flu-like symptoms. It is important to report any persistent or severe side effects to a healthcare provider.

Serostim should not be used in individuals who have active malignancies, diabetic retinopathy, or who are allergic to somatropin or any of the other ingredients in the medication. It is also important to inform the healthcare provider about any other medications or supplements being taken, as they may interact with Serostim.

Conclusion

Serostim (Somatropin Injectable) is a medication that is administered via subcutaneous injection. It is used for the treatment of HIV patients with wasting or cachexia 1. It contains somatropin, a synthetic version of human growth hormone, and is produced using recombinant DNA technology. As with any medication, it is important to follow the prescribed dosage and administration instructions, and to report any side effects or concerns to a healthcare provider.

references

• dailymed.nlm.n

• https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020604s040lbl.pdf

What Is Serostim?

Serostim [somatropin (rDNA origin) for injection] is a form of human growth hormone used to treat growth failure in children and adults who lack natural growth hormone, and in those with chronic kidney failure, Noonan syndrome, Turner syndrome, short stature at birth with no catch-up growth, and other causes. Serostim is also used to prevent severe weight loss in people with AIDS, or to treat short bowel syndrome.

How should I use Serostim?

Your dose and brand of somatropin, and how often you use it will depend on the condition you are treating. Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Serostim is injected into a muscle or under the skin. A healthcare provider can teach you how to properly use the medication by yourself.

What happens if I miss a dose?

Use the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not use two doses at one time.

Call your doctor if you miss more than 3 doses in a row.

What Are Side Effects of Serostim?

Common side effects of Serostim include:

• headache,
• nausea,
• vomiting,
• fatigue,
• muscle pain,
• weakness,
• injection site reactions (redness, soreness, swelling, rash, itching, pain, or bruising),
• pain in your arms or legs,
• joint stiffness or pain, or
• cold symptoms such as stuffy nose, sneezing, and sore throat.